US FDA accepts Camurus’ resubmission of NDA for Oclaiz for treatment of acromegaly: Lund, Sweden Monday, January 12, 2026, 15:00 Hrs [IST] Camurus, an international, science-led ...
Camurus AB ( (SE:CAMX) ) has issued an announcement.
PDUFA target action date set to 10 June 2026 LUND, Sweden, Jan. 9, 2026 /PRNewswire/ -- Camurus (NASDAQ STO: CAMX) today announced that the U.S. Food and ...
Apollo endocrinologist explains the key difference between belly fat and visceral fat, warning that even people with normal ...
Understanding the role of the gut-hormone axis in women’s health could open untapped opportunities for addressing complex ...
Everyday Health on MSN
My insurance won’t cover GLP-1 drugs. What now?
Today, the compounded GLP-1 market is in upheaval. The FDA has banned copies of GLP-1 weight loss drugs, and a number of ...
Type 2 diabetes has long been regarded as a chronic, lifelong disease requiring continuous medication in the form of tablets ...
Chronic liver disease gets worse when the liver's immune system stays overactive, resulting in ongoing inflammation and ...
A new study co-led by the Southern California Superfund Research and Training Program for PFAS Assessment, Remediation and ...
News-Medical.Net on MSN
Forever chemicals linked to higher liver disease risk in adolescents
A new study co-led by the Southern California Superfund Research and Training Program for PFAS Assessment, Remediation and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback